Aclaris Therapeutics, Inc. (ACRS)

USD 3.08

(-5.52%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 197.4 Million 254.59 Million 251.21 Million 70.78 Million 98.29 Million 275.56 Million
Total Current Assets 128.85 Million 231.55 Million 205.03 Million 57.49 Million 83.8 Million 179.49 Million
Cash And Short Term Investments 119.1 Million 229.81 Million 225.65 Million 54.13 Million 75.01 Million 167.97 Million
Cash and Cash Equivalents 39.87 Million 45.27 Million 27.34 Million 54.13 Million 35.93 Million 57.01 Million
Short Term Investments 79.22 Million 172.29 Million 164.06 Million 32.06 Million 39.07 Million 110.95 Million
Net Receivables 298 Thousand 484 Thousand 623 Thousand 772 Thousand 704 Thousand 4.86 Million
Inventory - -12.24 Million -34.24 Million - 4.96 Million 791 Thousand
Other Current Assets 9.45 Million 13.49 Million 12.99 Million 2.59 Million 3.11 Million 5.87 Million
Total Non-Current Assets 68.54 Million 23.04 Million 46.17 Million 13.29 Million 14.49 Million 96.06 Million
Net PPE 1.62 Million 1.09 Million 1.33 Million 1.65 Million 2.47 Million 4.28 Million
Good Will And Intangible Assets 269 Thousand 6.97 Million 7.04 Million 7.12 Million 7.19 Million 91.45 Million
Good Will - - - - - 18.5 Million
Intangible Assets 269 Thousand 6.97 Million 7.04 Million 7.12 Million 7.19 Million 72.95 Million
Long-Term Investments 62.77 Million 12.24 Million 34.24 Million - - -
Tax Assets 2.14 Million 3.36 Million - - - -
Other Non Current Assets 1.74 Million -630 Thousand 3.55 Million 4.51 Million 4.82 Million 332 Thousand
Other Assets - - - - - -
Total Liabilities 40.22 Million 56.97 Million 53.87 Million 33.13 Million 28.38 Million 60.44 Million
Total Current Liabilities 30.95 Million 21.93 Million 22.93 Million 14.87 Million 22.43 Million 27.34 Million
Account Payables 8.87 Million 10.35 Million 9.98 Million 5.25 Million 9.91 Million 14.75 Million
Tax Payables - - - - - -
Short Term Debt 426 Thousand 684 Thousand 693 Thousand 603 Thousand 637 Thousand 601 Thousand
Deferred Revenue 19.44 Million - 10.05 Million 5.9 Million 7.72 Million -
Other Current Liabilities 2.2 Million 10.9 Million 2.2 Million 3.11 Million 4.15 Million 11.98 Million
Total Non Current Liabilities 9.27 Million 35.03 Million 30.93 Million 18.26 Million 5.95 Million 33.1 Million
Long-Term Debt 3.07 Million 1.57 Million 2.17 Million 10.65 Million 3.56 Million 29.91 Million
Deferred Revenue Non Current -3.07 Million -1.57 Million -2.17 Million - -3.56 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 7.12 Million 34.67 Million 30.57 Million 7.24 Million 5.4 Million 2.63 Million
Other Liabilities - - - - - -
Total Equity 157.17 Million 197.62 Million 197.34 Million 37.65 Million 69.91 Million 215.12 Million
Stock Holders Equity 157.17 Million 197.62 Million 197.34 Million 37.65 Million 69.91 Million 215.12 Million
Common Stock 1000.00 1000.00 1000.00 - - -
Retained Earnings -770.79 Million -682.31 Million -595.4 Million -504.54 Million -453.52 Million -292.17 Million
Accumulated other comprehensive income -106 Thousand -897 Thousand -224 Thousand -94 Thousand -66 Thousand -69 Thousand
Common Stock Equity 157.17 Million 197.62 Million 197.34 Million 37.65 Million 69.91 Million 215.12 Million
Capital Lease Obligation 426 Thousand 684 Thousand 693 Thousand 603 Thousand 637 Thousand 601 Thousand
Total Investments 79.22 Million 184.53 Million 198.3 Million 32.06 Million 39.07 Million 110.95 Million
Total Debt 426 Thousand 684 Thousand 693 Thousand 11.25 Million 637 Thousand 30.51 Million
Net Debt -39.45 Million -44.59 Million -26.65 Million -42.87 Million -35.3 Million -26.5 Million

Balance Sheet Charts